Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines

  • Caroline Gest1Email author,
  • Ulrich Joimel1, 7,
  • Limin Huang1, 2,
  • Linda-Louise Pritchard3,
  • Alexandre Petit1,
  • Charlène Dulong1,
  • Catherine Buquet1,
  • Chao-Quan Hu2,
  • Pezhman Mirshahi4,
  • Marc Laurent1,
  • Françoise Fauvel-Lafève5,
  • Lionel Cazin1,
  • Jean-Pierre Vannier1,
  • He Lu2,
  • Jeannette Soria4, 6,
  • Hong Li1Email author,
  • Rémi Varin1 and
  • Claudine Soria1
Contributed equally
BMC Cancer201313:63

DOI: 10.1186/1471-2407-13-63

Received: 19 March 2012

Accepted: 30 January 2013

Published: 6 February 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
19 Mar 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
25 Mar 2012 Author responded Author comments - Caroline Gest
23 Apr 2012 Reviewed Reviewer Report - Lalita Shevde-Samant
29 Apr 2012 Reviewed Reviewer Report - Vimla Band
Resubmission - Version 3
25 Mar 2012 Submitted Manuscript version 3
14 Aug 2012 Author responded Author comments - Caroline Gest
27 Aug 2012 Reviewed Reviewer Report - Lalita Shevde-Samant
1 Sep 2012 Reviewed Reviewer Report - Vimla Band
Resubmission - Version 4
14 Aug 2012 Submitted Manuscript version 4
Publishing
30 Jan 2013 Editorially accepted
6 Feb 2013 Article published 10.1186/1471-2407-13-63

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Laboratoire MERCI - EA3829, Faculté de Médecine et de Pharmacie, Université de Rouen
(2)
INSERM UMR-S 728, IUH, Hôpital Saint-Louis
(3)
Université Paris-Sud and CNRS FRE 3377, CEA-Saclay
(4)
Department of Onco-Haematology, UMRS 872, CNRS, E 18, INSERM, Université Paris VI
(5)
INSERM U553, Hôpital Saint-Louis
(6)
Unité Fonctionnelle Oncologie Médicale, Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris (AP-HP)
(7)
Unité Fonctionnelle Oncologie Médicale, Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris (AP-HP)

Advertisement